New imaging modalities in bladder cancer

World Journal of Urology

Volumn 24, Issue 5, 2006, Pages 473-480

  Saksena, Mansi A ^a   Dahl, Douglas M ^a   Harisinghani, Mukesh G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER TUMOR; CANCER STAGING; CYSTOSCOPY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; METASTASIS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SCINTISCANNING;

CYSTOSCOPY; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 33751214211     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-006-0118-7     Document Type: Article

References (45)

1. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106-130
2. Soloway MS, Sofer M, Vaidya A (2002) Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 167:1573-1583
3. Saad A, Hanbury DC, McNicholas TA, Boustead GB, Morgan S, Woodman AC (2002) A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU Int 89:369-373
4. Jichlinski P (2003) New diagnostic strategies in the detection and staging of bladder cancer. Curr Opin Urol 13:351-355
5. Mallampati GK, Siegelman ES (2004) MR imaging of the bladder. Magn Reson Imaging Clin N Am 12:545-555, vii
6. Dobson MJ, Carrington BM, Collins CD et al (2001) The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol 56:94-98
7. Tekes A, Kamel I, Imam K et al (2005) Dynamic MRI of bladder cancer: Evaluation of staging accuracy. AJR Am J Roentgenol 184:121-127
8. Arslan H, Ceylan K, Harman M, Yilmaz Y, Temizoz O, Can S (2006) Virtual computed tomography cystoscopy in bladder pathologies. Int Braz J Urol 32:147-154; discussion 154 147-154; discussion 154
9. Kagadis GC, Siablis D, Liatsikos EN, Petsas T, Nikiforidis GC (2006) Virtual endoscopy of the urinary tract. Asian J Androl 8:31-38
10. Braticevici B, Onu M, Bengus F (2006) Virtual cystoscopy - a surgical planning and guidance tool. Arch Ital Urol Androl 78:23-24
11. Browne RF, Murphy SM, Grainger R, Hamilton S (2005) CT cystography and virtual cystoscopy in the assessment of new and recurrent bladder neoplasms. Eur J Radiol 53:147-153
12. Tsili AC, Tsampoulas C, Chatziparaskevas N et al (2004) Computed tomographic virtual cystoscopy for the detection of urinary bladder neoplasms. Eur Urol 46:579-585
13. Kishore TA, George GK, Bhat S (2006) Virtual cystoscopy by intravesical instillation of dilute contrast medium: Preliminary experience. J Urol 175:870-874
14. Kawai N, Mimura T, Nagata D, Tozawa K, Kohri K (2004) Intravenous urography-virtual cystoscopy is a better preliminary examination than air virtual cystoscopy. BJU Int 94:832-836
15. Yazgan C, Fitoz S, Atasoy C, Turkolmez K, Yagci C, Akyar S (2004) Virtual cystoscopy in the evaluation of bladder tumors. Clin Imaging 28:138-142
16. Beer A, Saar B, Rummeny EJ (2003) Tumors of the urinary bladder: technique, current use, and perspectives of MR and CT cystography. Abdom Imaging 28:868-876
17. Beer A, Saar B, Zantl N et al (2004) MR cystography for bladder tumor detection. Eur Radiol 14:2311-2319
18. Bernhardt TM, Schmidl H, Philipp C, Allhoff EP, Rapp-Bernhardt U (2003) Diagnostic potential of virtual cystoscopy of the bladder: MRI vs CT. Preliminary report. Eur Radiol 13:305-312
19. Nambirajan T, Sohaib SA, Muller-Pollard C, Reznek R, Chinegwundoh FI (2004) Virtual cystoscopy from computed tomography: A pilot study. BJU Int 94:828-831
20. Prando A (2002) CT-virtual endoscopy of the urinary tract. Int Braz J Urol 28:317-322
21. Russell ST, Kawashima A, Vrtiska TJ et al (2005) Three-dimensional CT virtual endoscopy in the detection of simulated tumors in a novel phantom bladder and ureter model. J Endourol 19:188-192
22. Kim JK, Park SY, Kim HS, Kim SH, Cho KS (2005) Comparison of virtual cystoscopy, multiplanar reformation, and source CT images with contrast material-filled bladder for detecting lesions. AJR Am J Roentgenol 185:689-696
23. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295-1298
24. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19:666-675
25. Bajorin DF (2001) Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer. J Clin Oncol 19:17S-20S
26. Millikan R, Dinney C, Swanson D et al (2001) Integrated therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19:4005-4013
27. Kosuda S, Kison PV, Greenough R, Grossman HB, Wahl RL (1997) Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med 24:615-620
28. Bachor R, Kotzerke J, Reske SN, Hautmann R (1999) Lymph node staging of bladder neck carcinoma with positron emission tomography. Urologe A 38:46-50
29. Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L (2005) FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 32:1412-1417
30. Hain SF (2005) Positron emission tomography in uro-oncology. Cancer Imaging 5:1-7
31. Machtens S, Boerner AR, Hofmann M, Knapp WH, Jonas U (2004) Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors. Urologe A 43:1397-1409
32. Bellin MF, Lebleu L, Meric JB (2003) Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 28:155-163
33. Bellin MF, Roy C, Kinkel K et al (1998) Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles-initial clinical experience. Radiology 207:799-808
34. Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491-2499
35. Harisinghani MG, Barentsz JO, Hahn PF et al (2002) MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. Acad Radiol 9(Suppl 2):S312-S313
36. Harisinghani MG, Saini S, Hahn PF, Weissleder R, Mueller PR (1998) MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (combidex). Acad Radiol 5(Suppl 1):S167-S169, discussion S183-S184
37. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ (1990) Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175:494-498
38. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L (1990) Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MR imaging. Radiology 175:489-493
39. Koenig SH, Kellar KE (1995) Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 34:227-233
40. Guimaraes R, Clement O, Bittoun J, Carnot F, Frija G (1994) MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. AJR Am J Roentgenol 162:201-207
41. Clement O, Guimaraes R, de Kerviler E, Frija G (1994) Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles. Invest Radiol 29(Suppl 2):S226-S228
42. Anzai Y, Piccoli CW, Outwater EK et al (2003) Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: Phase III safety and efficacy study. Radiology 28:777-788
43. Hudgins PA, Anzai Y, Morris MR, Lucas MA (2002) Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: A phase 2 dose study. AJNR Am J Neuroradiol 23:649-656
44. Harisinghani MG, Dixon WT, Saksena MA et al (2004) MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 24:867-878
45. Deserno WM, Harisinghani MG, Taupitz M et al (2004) Urinary bladder cancer: Preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233:449-456